Endiatx
Endiatx is an ingestible pill-sized robot for sedation-free endoscopic diagnostics and treatment. The company completed its first-in-human in 2020, signed an agreement with the Mayo Clinic in 2023, and raised Series A funding.
Endiatx is active in the founder institute graduate space based in Silicon Valley, US.
As a business in founder institute graduate, Endiatx is listed here with the public details available about it.
Its base of operations is Silicon Valley, US.
The company is listed at the Founder Institute graduate stage of development.
| Sector | Founder Institute graduate |
|---|---|
| Headquarters | Silicon Valley, US |
| Country | United States |
| Stage | Founder Institute graduate |
Website: endiatx.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account